Eren, O. C. Et Al. 2024. Subgrading of G2 Pancreatic Neuroendocrine Tumors as 2A (Ki67 3% to < 10%) Versus 2B (10% to ≤ 20%) Identifies Behaviorally Distinct Subsets in Keeping with the Evolving Management Protocols. ANNALS OF SURGICAL ONCOLOGY .

Eren, O. C., BAĞCI ÇULÇİ, P., Balci, S., Ohike, N., Saka, B., SÖKMENSÜER, C., ... LEBLEBİCİ, C. B.(2024). Subgrading of G2 Pancreatic Neuroendocrine Tumors as 2A (Ki67 3% to < 10%) Versus 2B (10% to ≤ 20%) Identifies Behaviorally Distinct Subsets in Keeping with the Evolving Management Protocols. ANNALS OF SURGICAL ONCOLOGY .

Eren, Ozgur Et Al. "Subgrading of G2 Pancreatic Neuroendocrine Tumors as 2A (Ki67 3% to < 10%) Versus 2B (10% to ≤ 20%) Identifies Behaviorally Distinct Subsets in Keeping with the Evolving Management Protocols," ANNALS OF SURGICAL ONCOLOGY , 2024

Eren, Ozgur C. Et Al. "Subgrading of G2 Pancreatic Neuroendocrine Tumors as 2A (Ki67 3% to < 10%) Versus 2B (10% to ≤ 20%) Identifies Behaviorally Distinct Subsets in Keeping with the Evolving Management Protocols." ANNALS OF SURGICAL ONCOLOGY , 2024

Eren, O. C. Et Al. (2024) . "Subgrading of G2 Pancreatic Neuroendocrine Tumors as 2A (Ki67 3% to < 10%) Versus 2B (10% to ≤ 20%) Identifies Behaviorally Distinct Subsets in Keeping with the Evolving Management Protocols." ANNALS OF SURGICAL ONCOLOGY .

@article{article, author={Ozgur Can Eren Et Al. }, title={Subgrading of G2 Pancreatic Neuroendocrine Tumors as 2A (Ki67 3% to < 10%) Versus 2B (10% to ≤ 20%) Identifies Behaviorally Distinct Subsets in Keeping with the Evolving Management Protocols}, journal={ANNALS OF SURGICAL ONCOLOGY}, year=2024}